Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.
View Top Employees from ELIXXERWebsite | http://www.elixxer.com |
Ticker | CVE:ELXR |
Employees | 4 (0 on RocketReach) |
Founded | 2016 |
Address | 800 Square-victoria Ste 3700, Montreal, Quebec H4Z 1E9, CA |
Phone | (514) 788-1499 |
Industry | Tobacco, Drug Stores & Pharmacies, Venture Capital, Chemicals, Retail, Financial Services, Information Technology and Services, Lending and Investments, Venture Capital & Private Equity |
Competitors | ACIC Pharmaceuticals Inc., Mandara Pharma |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular ELIXXER employee's phone or email?
ELIXXER is based in Montreal, Quebec.
The NAICS codes for ELIXXER are [325, 32541, 3254, 32].
The SIC codes for ELIXXER are [28, 283].